Matches in SemOpenAlex for { <https://semopenalex.org/work/W2003243316> ?p ?o ?g. }
Showing items 1 to 80 of
80
with 100 items per page.
- W2003243316 abstract "Proceedings: AACR 104th Annual Meeting 2013; Apr 6-10, 2013; Washington, DCWe recently showed that poly(ADP-ribose) polymerase (PARP) inhibitors act by a novel allosteric mechanism of action that involves the trapping of PARP-DNA complexes in addition to their previously established NAD-competitive catalytic inhibitory mechanism). We also demonstrated that PARP inhibitors differ in their ability to trap PARP-DNA complexes, with olaparib being more effective than veliparib in spite of their comparable potency as catalytic PARP inhibitors). Here, by using PARP knockout cells, olaparib and veliparib, we tested the role of PARP trapping in the potentiating effect of PARP inhibitors with the alkylating agent temozolomide and the topoisomerase I inhibitor, camptothecin. Using isogenic chicken DT40 cells, we show that PARP-dependent potentiation of temozolomide is markedly greater for olaparib than veliparib, and goes beyond knocking out PARP-1. On the other hand, in the case of camptothecin, knocking out PARP-1 has a greater effect than veliparib or olaparib. In human DU145 prostate cancer and SF295 glioblastoma cells, olaparib is markedly more potent than veliparib in potentiating the cytotoxicity of temozolomide whereas both olaparib and veliparib are almost comparable in the case of camptothecin. By measuring cellular PARP-DNA complexes), we find that in the case of temozolomide, olaparib is a least 10-fold more potent than veliparib at trapping PARP-DNA complexes. On the other hand, in the case of camptothecin, neither olaparib nor veliparib produced detectable trapping of PARP-DNA complexes. Finally, olaparib fails to sensitize DT40, DU145 or SF295 cells to cisplatin and does not induce detectable PARP-DNA complexes in cisplatin-treated cells. These results suggest that, in the case of temozolomide, olaparib trapping of PARP-DNA complexes is more toxic than inactivating PARP catalytic activity, which is not the case for topoisomerase I-induced DNA damage, where catalytic inactivation of PARP appears to be the sole enhancing mechanism.Citation Format: Yves G. Pommier, Junko Murai. Differential potentiation of temozolomide and camptothecin by the PARP inhibitors olaparib and veliparib in relationship with their PARP-DNA trapping abilities, and lack of impact of PARP inhibitors on cisplatin activity. [abstract]. In: Proceedings of the 104th Annual Meeting of the American Association for Cancer Research; 2013 Apr 6-10; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2013;73(8 Suppl):Abstract nr 3421. doi:10.1158/1538-7445.AM2013-3421" @default.
- W2003243316 created "2016-06-24" @default.
- W2003243316 creator A5042114293 @default.
- W2003243316 creator A5074228660 @default.
- W2003243316 date "2013-04-15" @default.
- W2003243316 modified "2023-09-25" @default.
- W2003243316 title "Abstract 3421: Differential potentiation of temozolomide and camptothecin by the PARP inhibitors olaparib and veliparib in relationship with their PARP-DNA trapping abilities, and lack of impact of PARP inhibitors on cisplatin activity." @default.
- W2003243316 doi "https://doi.org/10.1158/1538-7445.am2013-3421" @default.
- W2003243316 hasPublicationYear "2013" @default.
- W2003243316 type Work @default.
- W2003243316 sameAs 2003243316 @default.
- W2003243316 citedByCount "0" @default.
- W2003243316 crossrefType "proceedings-article" @default.
- W2003243316 hasAuthorship W2003243316A5042114293 @default.
- W2003243316 hasAuthorship W2003243316A5074228660 @default.
- W2003243316 hasConcept C121608353 @default.
- W2003243316 hasConcept C126322002 @default.
- W2003243316 hasConcept C182979987 @default.
- W2003243316 hasConcept C185592680 @default.
- W2003243316 hasConcept C2776438761 @default.
- W2003243316 hasConcept C2777389519 @default.
- W2003243316 hasConcept C2778227246 @default.
- W2003243316 hasConcept C2779138821 @default.
- W2003243316 hasConcept C2779682216 @default.
- W2003243316 hasConcept C2779723316 @default.
- W2003243316 hasConcept C2779962180 @default.
- W2003243316 hasConcept C2781312401 @default.
- W2003243316 hasConcept C502942594 @default.
- W2003243316 hasConcept C552990157 @default.
- W2003243316 hasConcept C55493867 @default.
- W2003243316 hasConcept C71924100 @default.
- W2003243316 hasConcept C82381507 @default.
- W2003243316 hasConcept C96232424 @default.
- W2003243316 hasConcept C98274493 @default.
- W2003243316 hasConceptScore W2003243316C121608353 @default.
- W2003243316 hasConceptScore W2003243316C126322002 @default.
- W2003243316 hasConceptScore W2003243316C182979987 @default.
- W2003243316 hasConceptScore W2003243316C185592680 @default.
- W2003243316 hasConceptScore W2003243316C2776438761 @default.
- W2003243316 hasConceptScore W2003243316C2777389519 @default.
- W2003243316 hasConceptScore W2003243316C2778227246 @default.
- W2003243316 hasConceptScore W2003243316C2779138821 @default.
- W2003243316 hasConceptScore W2003243316C2779682216 @default.
- W2003243316 hasConceptScore W2003243316C2779723316 @default.
- W2003243316 hasConceptScore W2003243316C2779962180 @default.
- W2003243316 hasConceptScore W2003243316C2781312401 @default.
- W2003243316 hasConceptScore W2003243316C502942594 @default.
- W2003243316 hasConceptScore W2003243316C552990157 @default.
- W2003243316 hasConceptScore W2003243316C55493867 @default.
- W2003243316 hasConceptScore W2003243316C71924100 @default.
- W2003243316 hasConceptScore W2003243316C82381507 @default.
- W2003243316 hasConceptScore W2003243316C96232424 @default.
- W2003243316 hasConceptScore W2003243316C98274493 @default.
- W2003243316 hasLocation W20032433161 @default.
- W2003243316 hasOpenAccess W2003243316 @default.
- W2003243316 hasPrimaryLocation W20032433161 @default.
- W2003243316 hasRelatedWork W2016058914 @default.
- W2003243316 hasRelatedWork W2061037947 @default.
- W2003243316 hasRelatedWork W2098122970 @default.
- W2003243316 hasRelatedWork W2118280785 @default.
- W2003243316 hasRelatedWork W2151517816 @default.
- W2003243316 hasRelatedWork W2156500939 @default.
- W2003243316 hasRelatedWork W2164872561 @default.
- W2003243316 hasRelatedWork W2328149723 @default.
- W2003243316 hasRelatedWork W2328979501 @default.
- W2003243316 hasRelatedWork W2404848607 @default.
- W2003243316 hasRelatedWork W2503626267 @default.
- W2003243316 hasRelatedWork W2527062344 @default.
- W2003243316 hasRelatedWork W2555354504 @default.
- W2003243316 hasRelatedWork W2589880296 @default.
- W2003243316 hasRelatedWork W2885830402 @default.
- W2003243316 hasRelatedWork W2885866858 @default.
- W2003243316 hasRelatedWork W2955280685 @default.
- W2003243316 hasRelatedWork W3107459115 @default.
- W2003243316 hasRelatedWork W3178027290 @default.
- W2003243316 hasRelatedWork W3178888999 @default.
- W2003243316 isParatext "false" @default.
- W2003243316 isRetracted "false" @default.
- W2003243316 magId "2003243316" @default.
- W2003243316 workType "article" @default.